ribavirin has been researched along with Medulloblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brem, H; Casaos, J; Cecia, A; Ding, AS; Ehresman, J; Felder, R; Gorelick, NL; Huq, S; Kannapadi, NV; Lott, T; Medikonda, R; Ruiz-Cardozo, MA; Serra, R; Skuli, N; Tyler, BM | 1 |
1 other study(ies) available for ribavirin and Medulloblastoma
| Article | Year |
|---|---|
Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cerebellar Neoplasms; Enhancer of Zeste Homolog 2 Protein; Eukaryotic Initiation Factor-4E; Hedgehog Proteins; Humans; Medulloblastoma; Mice; Ribavirin; Xenograft Model Antitumor Assays | 2021 |